Special Issue "Advances in Genomics and Molecular Pathology of Rare Cancers—Focus on Diverse Populations"
Deadline for manuscript submissions: 10 December 2023 | Viewed by 2681
Interests: molecular pathobiology of lymphomas and rare cancers
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance 2.0
Rare cancers collectively represent a major healthcare problem worldwide, comprising a neglected group of diseases with poorly defined therapeutic strategies and dismal outcomes. In addition, the overall health burden is compounded by the fact that rare cancers disproportionately affect adolescents and young adults—a susceptible cohort whose prognosis has not improved to the same extent as those for children and older adults with cancer. Globally, the distribution of rare cancers exhibits ethnogeographic variation depending on genetic and environmental factors; the latter may include unique oncopathogens or carcinogens. As the genomic and molecular landscapes of the most prevalent cancers have been unraveled in recent decades, there is now greater impetus and opportunity to study rare cancers for translational discovery.
In this Special Issue, tumor types of interest include soft tissue and bone sarcomas, as well as rare subtypes of lymphomas, melanomas, and epithelial malignancies. New research regarding the genomic and molecular landscapes of rare cancers will be highlighted, with a focus on advancements with clinical and biological applications.
Dr. Yong Sheng Jason Chan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- soft tissue sarcoma
- bone sarcoma
- adolescent and young adult oncology
- global oncology
- targeted therapy